Hcy、hs-CRP和CysC与颈动脉粥样硬化的相关性研究进展
Research Progress on the Correlation between Hcy, hs-CRP, CysC and Carotid Atherosclerosis
DOI: 10.12677/ACM.2023.13122741, PDF,    科研立项经费支持
作者: 蒋 叶:新疆医科大学第四临床医学院,新疆 乌鲁木齐;王永康:新疆医科大学研究生学院,新疆 乌鲁木齐;买买提·依斯热依力:新疆维吾尔自治区人民医院,科教中心,新疆 乌鲁木齐;李 岚*:新疆医科大学第四临床医学院,新疆 乌鲁木齐;新疆医科大学第四临床医学院,心血管内科,新疆 乌鲁木齐
关键词: 超敏C反应蛋白同型半胱氨酸胱抑素C颈动脉粥样硬化炎性细胞因子Hypersensitive C-Reactive Protein Homocysteine Cystatin C Carotid Atherosclerosis Cytokines
摘要: 在过去的几十年中,基础和临床研究积累的证据一致表明,炎症参与了颈动脉粥样硬化(Carotid Atherosclerosis, CAS)的发生发展过程,并在其中发挥着关键而复杂的作用。值得思考的是,伴随着相关炎症因子水平的增加,同时也预示着心血管事件发生率的升高。高敏C反应蛋白(High-Sensitivity C-Reactive protein, hs-CRP)是一种非特异性炎性细胞因子,通过增加炎症细胞浸润、增加氧化应激以及损害血管内皮的功能,hs-CRP加速动脉粥样硬化斑块的形成和破坏。同样,同型半胱胺酸(Homocysteine, Hcy)能够参与多机制的血管内皮功能受损,同时刺激血管平滑肌细胞增生,内皮细胞能够调节血管张力、通透性、炎症和细胞生长,在维持血管壁稳态方面起着关键作用。Hcy诱导的血管损伤结局最终影响了血流通路。以及酰化反应导致血栓、颈动脉粥样硬化的产生。然而,血清胱抑素C (Cystatin C, CysC) CysC作为半胱氨酸蛋白酶的抑制剂,在动脉粥样硬化的发病机制中起着重要作用。高水平的胱抑素C可能通过调节蛋白水解和抗蛋白水解活性的平衡直接影响血管壁重塑的过程。以及,胱抑素C可能具有直接的毒性作用,导致其与中风和其他心血管事件的风险相关联。
Abstract: In the past decades, the evidence accumulated from basic and clinical research has consistently shown that inflammation is involved in the occurrence and development of carotid atherosclerosis, and plays a key and complex role in it. It is worth considering that the increase in levels of related inflammatory factors also indicates an increase in the incidence of cardiovascular events. High sen-sitivity C-reactive protein (hs-CRP) is a non-specific inflammatory cytokine. By increasing inflam-matory cell infiltration, increasing oxidative stress and damaging the function of vascular endothe-lium, hs-CRP accelerates the formation and destruction of atherosclerotic plaque. Similarly, homo-cysteine (Hcy) can participate in multiple mechanisms of impaired endothelial function and stimu-late the proliferation of vascular smooth muscle cells. Endothelial cells can regulate vascular ten-sion, permeability, inflammation, and cell growth, playing a crucial role in maintaining vascular wall homeostasis. The outcome of Hcy induced vascular injury ultimately affects the blood flow pathway. And acylation reaction leads to thrombosis and carotid atherosclerosis. However, serum cystatin C (CysC) CysC, as an inhibitor of cysteine protease, plays an important role in the pathogenesis of ath-erosclerosis. High levels of cystatin C may directly affect the process of vascular wall remodeling by regulating the balance between protein hydrolysis and anti protein hydrolysis activity. Moreover, cystatin C may have direct toxic effects, leading to its association with the risk of stroke and other cardiovascular events.
文章引用:蒋叶, 王永康, 买买提·依斯热依力, 李岚. Hcy、hs-CRP和CysC与颈动脉粥样硬化的相关性研究进展[J]. 临床医学进展, 2023, 13(12): 19471-19478. https://doi.org/10.12677/ACM.2023.13122741

参考文献

[1] Paraskevas, K.I. and Sillesen, H.H. (2020) Carotid Atherosclerosis Markers and Adverse Cardiovascular Events. Inter-national Journal of Cardiology, 307, 178. [Google Scholar] [CrossRef] [PubMed]
[2] 孙蔚, 王慧丽, 岳媛媛, 等. 血清炎症因子白细胞介素-18、高敏C反应蛋白、肿瘤坏死因子-α与2型糖尿病患者颈动脉粥样硬化的关系[J]. 临床内科杂志, 2023, 40(4): 265-267.
[3] Goikuria, H., Vandenbroeck, K. and Alloza, I. (2018) Inflamma-tion in Human Carotid Atheroma Plaques. Cytokine & Growth Factor Reviews, 39, 62-70. [Google Scholar] [CrossRef] [PubMed]
[4] 钟子安, 刘娟, 杨柳, 等. 基于Nox4/NLRP3通路探讨桃叶珊瑚苷干预动脉粥样硬化的作用机制[J]. 中西医结合心脑血管病杂志, 2023, 21(13): 2405-2411.
[5] van Leent, M.M.T., Beldman, T.J., Toner, Y.C., et al. (2021) Prosaposin Mediates Inflammation in Atherosclerosis. Science Trans-lational Medicine, 13, eabe1433. [Google Scholar] [CrossRef] [PubMed]
[6] 颜因, 刘多, 李承, 等. 急性脑梗死患者血管内皮功能、Hcy水平及预后分析[J]. 实用临床医药杂志, 2016, 20(9): 10-13.
[7] 邓远琼, 刘伯胜, 邓远琪, 等. 急性脑梗死患者血管内皮功能和同型半胱氨酸水平变化及其治疗[J]. 中国全科医学, 2013, 16(32): 3057-3061.
[8] Esse, R., Barroso, M., Tavares de Almeida, I. and Castro, R. (2019) The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art. International Journal of Molecular Sciences, 20, Article 867. [Google Scholar] [CrossRef] [PubMed]
[9] Fittipaldi, S., Pini, R., Pasquinelli, G., et al. (2016) High Sensitivity C-Reactive Protein and Vascular Endothelial Growth Factor as Indicators of Carotid Plaque Vulnerability. The Journal of Cardiovascular Surgery, 57, 861-871.
[10] Umemura, T., Kawamura, T., Mashita, S., et al. (2016) Higher Levels of Cystatin C Are Associated with Extracranial Carotid Artery Steno-Occlusive Disease in Patients with Noncardioembolic Ischemic Stroke. Cerebrovascular Diseases Extra, 6, 1-11. [Google Scholar] [CrossRef] [PubMed]
[11] Chen, A., Wu, W., Gong, J., et al. (2023) Association of Homocysteine with Carotid Atherosclerosis in Hypertension. Journal of Hu-man Hypertension, 37, 227-234. [Google Scholar] [CrossRef] [PubMed]
[12] Catena, C., Colussi, G., Url-Michitsch, M., et al. (2015) Subclinical Carotid Artery Disease and Plasma Homocysteine Levels in Patients with Hypertension. Journal of the American Society of Hypertension, 9, 167-175. [Google Scholar] [CrossRef] [PubMed]
[13] Piazzolla, G., Candigliota, M., Fanelli, M., et al. (2019) Hyperho-mocysteinemia Is an Independent Risk Factor of Atherosclerosis in Patients with Metabolic Syndrome. Diabetology & Metabolic Syndrome, 11, Article No. 87. [Google Scholar] [CrossRef] [PubMed]
[14] 张帅. 炎性微环境靶向性纳米酶在动脉粥样硬化和缺血再灌注损伤治疗中的应用研究[D]: [博士学位论文]. 长春: 吉林大学, 2023.
[15] 王道鑫, 张添光, 缪朝玉. 血管内皮细胞线粒体氧化应激与动脉粥样硬化[J]. 药学实践与服务, 2023, 41(6): 329-334, 388.
[16] Kattoor, A.J., Pothineni, N.V.K., Palagiri, D. and Mehta, J.L. (2017) Oxidative Stress in Atherosclerosis. Current Atherosclerosis Reports, 19, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
[17] Marchio, P., Guerra-Ojeda, S., Vila, J.M., et al. (2019) Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 8563845. [Google Scholar] [CrossRef] [PubMed]
[18] 梁学飞, 马致远, 张永春, 等. SIRT1/LOX-1通路在同型半胱氨酸介导的动脉粥样硬化中作用的研究进展[J]. 医学综述, 2021, 27(8): 1487-1492.
[19] 殷玲. 高同型半胱氨酸血症与炎性反应疾病研究进展[J]. 国际检验医学杂志, 2020, 41(2): 228-232.
[20] 孙翔, 谭杰. 超声造影在检测冠心病颈动脉斑块内新生血管中的作用及与血清Hcy的关系[J]. 影像科学与光化学, 2022, 40(6): 1402-1406.
[21] Jia, J., Wang, A., Wang, J., et al. (2016) Homocysteine and Its Relationship to Asympto-Matic Carotid Stenosis in a Chinese Community Population. Scientific Reports, 6, Article No. 37361. [Google Scholar] [CrossRef] [PubMed]
[22] 孙文萍, 汤雪晴, 谢春香, 等. 同型半胱氨酸对血管内皮细胞核转录因子及细胞间黏附分子的影响[J]. 中华老年心脑血管病杂志, 2011, 13(6): 554-556.
[23] Kones, R. (2011) Primary Prevention of Coronary Heart Disease: Integration of New Data, Evolving Views, Revised Goals, and Role of Rosuvastatin in Management. A Comprehensive Survey. Drug Design, Development and Therapy, 5, 325-380. [Google Scholar] [CrossRef
[24] Eisenhardt, S.U., Ha-bersberger, J., Murphy, A., et al. (2009) Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques. Circulation Research, 105, 128-137. [Google Scholar] [CrossRef
[25] Georgakis, M.K., Malik, R., Richardson, T.G., et al. (2022) Associations of Genetically Predicted IL-6 Signaling with Cardiovascular Disease Risk across Population Sub-groups. BMC Medicine, 20, Article No. 245. [Google Scholar] [CrossRef] [PubMed]
[26] Yuksel, B., Koc, P., Ozaydin Goksu, E., et al. (2021) Is Multiple Sclerosis a Risk Factor for Atherosclerosis? Journal of Neuroradiology, 48, 99-103. [Google Scholar] [CrossRef] [PubMed]
[27] Mayer, F.J., Binder, C.J., Wagner, O.F., et al. (2016) Combined Effects of Inflammatory Status and Carotid Atherosclerosis: A 12-Year Follow-Up Study. Stroke. 47, 2952-2958. [Google Scholar] [CrossRef
[28] Zhang, Q., Wu, C., Liu, Y., et al. (2023) Chronic Inflam-mation Plays a Role of a Bridge between Cardiovascular Disease and Hyperglycemia. Metabolic Syndrome and Related Disorders, 21, 468-474. [Google Scholar] [CrossRef] [PubMed]
[29] Kadoglou, N.P.E., Moulakakis, K.G., Mantas, G., et al. (2022) The Association of Arterial Stiffness with Significant Carotid Atherosclerosis and Carotid Plaque Vulnerability. Angiology, 73, 668-674. [Google Scholar] [CrossRef] [PubMed]
[30] Scimeca, M., Montanaro, M., Cardellini, M., et al. (2021) High Sensitivity C-Reactive Protein Increases the Risk of Carotid Plaque Instability in Male Dyslipidemic Patients. Diagnostics, 11, Article 2117. [Google Scholar] [CrossRef] [PubMed]
[31] Shindo, A., Tanemura, H., Yata, K., et al. (20140 Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability. PLOS ONE, 9, e100045.[CrossRef] [PubMed]
[32] Zhou, Y., Han, W., Gong, D., et al. (2016) Hs-CRP in Stroke: A Meta-Analysis. Clinica Chimica Acta, 453, 21-27. [Google Scholar] [CrossRef] [PubMed]
[33] 樊蓉, 任卫东. 超声评估冠状动脉粥样硬化性心脏病患者二尖瓣环移位参数及其与血清Hcy、vWF及CysC水平的相关性研究[J]. 中国现代医学杂志, 2020, 30(13): 23-26.
[34] Eriksson, P., Deguchi, H., Samnegård, A., et al. (2004) Human Evidence that the Cystatin C Gene Is Impli-cated in Focal Progression of Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 551-557. [Google Scholar] [CrossRef
[35] Shi, G.P., Sukhova, G.K., Grubb, A., et al. (1999) Cystatin C Deficiency in Human Atherosclerosis and Aortic Aneurysms. Journal of Clinical Investigation, 104, 1191-1197. [Google Scholar] [CrossRef
[36] Cheng, X.W., Kuzuya, M., Sasaki, T., et al. (2004) Increased Expression of Elastolytic Cysteine Proteases, Cathepsins S and K, in the Neointima of Balloon-Injured Rat Carotid Ar-teries. The American Journal of Pathology, 164, 243-251. [Google Scholar] [CrossRef
[37] Bengtsson, E., To, F., Håkansson, K., et al. (2005) Lack of the Cysteine Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice. Arteriosclero-sis, Thrombosis, and Vascular Biology, 25, 2151-2156. [Google Scholar] [CrossRef
[38] Luo, F., Luo, J.Y., Liu, F., et al. (2023) Coronary Ar-tery Calcium and Cystatin C for Risk Stratification of MACCEs and All-Cause Death in Symptomatic Patients. Clinical Cardiology, 46, 195-203. [Google Scholar] [CrossRef] [PubMed]
[39] Jasir, A., Kasprzykowski, F., Kasprzykowska, R., et al. (2003) New Antimicrobial CYSTATIN C-BASED PEPTIDE ACTive against Gram-Positive Bacterial Pathogens, Including Methicillin-Resistant Staphylococcus aureus and Multiresistant Coagulase-Negative Staphy-Lococci. APMIS, 111, 1004-1010. [Google Scholar] [CrossRef] [PubMed]
[40] Wu, H., Du, Q., Dai, Q., et al. (2018) Cyste-ine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases. Journal of Atherosclerosis and Thrombosis, 25, 111-123. [Google Scholar] [CrossRef
[41] Wang, X. and Khalil, R.A. (2018) Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. Advances in Pharmacology, 81, 241-330. [Google Scholar] [CrossRef] [PubMed]
[42] Fraley, A.E. and Tsimikas, S. (2006) Clinical Applications of Circulating Oxidized Low-Density Lipoprotein Biomarkers in Cardiovascular Disease. Current Opinion in Lipidology, 17, 502-509. [Google Scholar] [CrossRef] [PubMed]
[43] Tsimikas, S., Lau, H.K., Han, K.R., et al. (2004) Per-cutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein (a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein. Circulation, 109, 3164-3170. [Google Scholar] [CrossRef
[44] 舒瑛. 胱抑素C与心血管疾病的关系[J]. 心血管病学进展, 2010, 31(5): 673-677.
[45] 王群, 鹿庆华, 蒋卫东, 等. 胱抑素C对氧化型低密度脂蛋白诱导的人血管平滑肌细胞凋亡的影响[J]. 中国病理生理杂志, 2008, 24(12): 2319-2323.
[46] Martinez, E., Martorell, J. and Riambau, V. (2020) Review of Serum Biomarkers in Carotid Atherosclerosis. Journal of Vascular Surgery, 71, 329-341. [Google Scholar] [CrossRef] [PubMed]
[47] 梁蕴瑜, 谢平畅, 钟言, 等. 外周血HCY、PLR及hs-CRP预测原发性高血压患者颈动脉粥样硬化的诊断效能[J]. 现代生物医学进展, 2021, 21(16): 3110-3114.